What the content outline covers
The NBNSC CNSC Candidate Handbook lists these task statements for Professional Practice:
- Applying ethical principles in nutrition support therapy (T48)
- Practicing within legal and regulatory standards (T49)
- Evaluating study design, methodology, statistical analysis and results (T50)
- Applying evidence-based practice principles (T51)
High-yield areas
- Artificial nutrition as a medical therapy that may be withheld or withdrawn; surrogate decision-making
- Feeding tubes in advanced dementia
- Study designs, bias and the hierarchy of evidence
- Sensitivity, specificity and predictive values of screening tools
- Relative and absolute risk, number needed to treat, confidence intervals
How to study it
Practice one or two statistics calculations a day until absolute risk reduction, number needed to treat and predictive values are quick. Read ASPEN's ethics position paper and the major position statements on feeding in advanced dementia, and practice applying autonomy, beneficence, nonmaleficence and justice to concrete cases.
Free practice questions: professional practice
Three questions from the bank, each with the answer, a rationale for every option and its source. Commit to an answer before you open each explanation.
Investigators planning a randomized trial of enteral versus parenteral nutrition in ICU patients note that the feeding route cannot be hidden from patients or bedside staff. They propose letting the enrolling physician choose the next sealed envelope, because they believe allocation concealment is impossible without blinding. Which response is most accurate?
Show answer and explanation
Answer: B. Allocation can still be concealed until enrollment even if blinding is impossible
A (incorrect): An objective outcome such as mortality reduces the risk of biased outcome measurement, but it does not protect against biased enrollment. Without concealment, the groups can differ in prognosis before treatment starts, which affects any outcome.
B (correct): Allocation concealment prevents those enrolling patients from knowing the upcoming assignment, and it protects the assignment step itself. Unlike blinding, concealment can always be implemented, so an open-label trial should still use a concealed method rather than envelopes the enrolling physician can choose or inspect.
C (incorrect): Concealment and blinding address different biases. Concealment protects allocation before and at enrollment, whereas blinding protects against biased care and outcome assessment after assignment.
D (incorrect): The choice of analysis population does not follow from whether a trial is open label. Intention-to-treat remains the usual primary analysis for a superiority trial, and it does not fix biased enrollment.
Reference: Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. Item 9 Allocation concealment mechanism; Box 1. https://pmc.ncbi.nlm.nih.gov/articles/PMC2844943/
A fictional randomized trial in 4,000 hospitalized adults compares two enteral feeding protocols. The investigators prespecified a 1-day reduction in hospital length of stay as the smallest difference that would change practice. Mean length of stay is 9.4 days with the standard protocol and 9.1 days with the new protocol (P = 0.002). How should the team interpret this result?
Show answer and explanation
Answer: A. Unlikely due to chance but smaller than the prespecified important difference, so not practice-changing
A (correct): A very small P value in a large trial can accompany a trivial effect. The 0.3-day difference is unlikely to be due to chance but is well below the 1-day threshold the investigators defined as important, so the size of the effect, not the P value, should drive the decision.
B (incorrect): The P value describes how compatible the data are with no difference; it does not measure how large or important the effect is. Clinical importance is judged against a threshold such as the prespecified 1-day difference.
C (incorrect): A small P value does not indicate a false-positive result. A large sample makes small true differences detectable, which is expected rather than suspicious.
D (incorrect): Length of stay is a patient-relevant and health-system outcome, not a laboratory surrogate. It can be interpreted directly; the issue is the size of the difference.
Reference: Schunemann HJ, Vist GE, Higgins JPT, et al. Chapter 15: Interpreting results and drawing conclusions. In: Higgins JPT, Thomas J, Chandler J, et al, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5. Cochrane; 2024. Section 15.3.2 P values and statistical significance; Section 15.3.1. https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current/chapter-15
A study reports that a bedside nutrition risk score has a sensitivity of 85% and a specificity of 75% for malnutrition, compared with a full dietitian assessment. What is the positive likelihood ratio of the score, rounded to one decimal place?
Show answer and explanation
Answer: C. 3.4
Worked calculation
- Step 1: Positive likelihood ratio = sensitivity / (1 - specificity).
- Step 2: 0.85 / (1 - 0.75) = 0.85 / 0.25 = 3.4.
- Result: 3.4. (Negative likelihood ratio = (1 - 0.85) / 0.75 = 0.15 / 0.75 = 0.2.)
A (incorrect): 0.2 is the negative likelihood ratio, (1 - sensitivity) / specificity. It describes how much a negative result lowers the odds of malnutrition, not how much a positive result raises them.
B (incorrect): 1.1 comes from dividing sensitivity by specificity (0.85 / 0.75 = 1.13). The denominator of the positive likelihood ratio is the false-positive rate (1 - specificity), not the specificity itself.
C (correct): The positive likelihood ratio is sensitivity divided by (1 - specificity): 0.85 / 0.25 = 3.4. A positive score multiplies the pretest odds of malnutrition by 3.4, a useful but moderate shift.
D (incorrect): 5.0 comes from specificity / (1 - sensitivity) = 0.75 / 0.15, which inverts the formula. This is the reciprocal of the negative likelihood ratio, not the positive likelihood ratio.
Reference: Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ. 2004;329(7458):168-169. Formulas for positive and negative likelihood ratios. https://pmc.ncbi.nlm.nih.gov/articles/PMC478236/
For exam preparation only, not clinical advice.
Practice 55+ professional practice questions, and the other three domains
Get 550+ practice questions across all four domains, a timed full-length mock (250 questions in 4 hours) or half-length mock (125 in 2 hours), worked steps for every calculation, and a rationale with its source for every answer, backed by a pass-or-refund guarantee. $199 USD, one time.
See the full question bankOne-time purchase · No subscription · Pass-or-refund guarantee
Other content domains
- Clinical Management (57%)
- Nutrition Assessment (31%)
- Process Management (5%)